Almirall, S.a.
Clinical trials sponsored by Almirall, S.a., explained in plain language.
-
New shot could help eczema sufferers who Don't respond to steroids
Disease control Not yet recruitingThis Phase 3 study tests whether lebrikizumab, an injectable drug, can safely and effectively treat nummular eczema in adults who haven't gotten enough relief from topical steroids or can't use them. About 270 participants will receive either lebrikizumab or a placebo injection. …
Phase: PHASE3 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for painful skin condition: experimental drug LAD328 enters phase 2 trial
Symptom relief Not yet recruitingThis study tests whether the experimental drug LAD328 can reduce symptoms of hidradenitis suppurativa, a chronic skin condition causing painful lumps. About 50 adults with moderate-to-severe disease will receive either LAD328 or a placebo. The main goal is to see if the drug lead…
Phase: PHASE2 • Sponsor: Almirall, S.A. • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC